Bio

Mr. Weisenfeld has been an investment banker since 1989. Mr. Weisenfeld became a Partner at MTS Health Partners in January 2008, primarily responsible for the development of the life sciences and medical technology practices. Prior to joining, Mr. Weisenfeld was a Managing Director in Banc of America Securities’ Corporate and Investment Banking Healthcare Group. Mr. Weisenfeld co-led the firm’s life sciences practice, providing capital raising and strategic advisory services to both publicly traded and private companies. Prior to joining Bank of America in 2003, Mr. Weisenfeld was a Managing Director at JP Morgan, leading its Healthcare M&A business across all sectors of healthcare since 1999. Mr. Weisenfeld joined Chase Securities, a predecessor company to JP Morgan, in 1997. Prior to joining Chase, Mr. Weisenfeld spent over five years in the M&A Group at Merrill Lynch. Throughout his career, Mr. Weisenfeld has worked on a range of advisory transactions including acquisitions, sale transactions and strategic relationships. Selected life sciences transactions include the sale of Celator to Jazz Pharmaceuticals, Acorda’s acquisitions of Civitas and Biotie, Otsuka’s acquisition of Avanir, the sale of AesRx to Baxter, the sale of NuPathe to Teva, the merger of Trimeris and Synageva, Reata’s strategic partnership with Abbott Labs, Genzyme’s acquisition of Bioenvision, the sale of Corixa to GlaxoSmithKline, the sale of TKT to Shire, the sale of ALZA to J&J, the sale of BioChem Pharma to Shire, Lundbeck’s acquisition of Synaptic, and the sale of Gilead’s oncology assets to OSI. Mr. Weisenfeld has also been responsible for many life sciences financings, including acting as advisor in the Alder, Tracon and NuPathe IPOs. Mr. Weisenfeld is a board member of Public Health Solutions, a New York based not-for-profit and a member of the scientific advisory committee of Weill Cornell Medical School’s Daedalus Fund for Innovation as well as being a member of the school’s Dean’s Council. Mr. Weisenfeld holds an MBA from The Wharton School at the University of Pennsylvania and a BS from Cornell University.